Skip to main content
main-content

29-03-2018 | Gout | Article

Cardiovascular safety of febuxostat or allopurinol in patients with gout

White WB et al. N Eng J Med 2018; 378: 1200–1210. doi: 10.1056/NEJMoa1710895

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

http://dx.doi.org/10.1056/NEJMoa1710895

Related topics